Literature DB >> 22411879

Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries.

Lidija Kamara1, Patrick Lydon, Julian Bilous, Jos Vandelaer, Rudi Eggers, Marta Gacic-Dobo, William Meaney, Jean-Marie Okwo-Bele.   

Abstract

Within the overall framework set out in the Global Immunization Vision and Strategy (GIVS) for the period 2006-2015, over 70 countries had developed comprehensive Multi-Year Plans (cMYPs) by 2008, outlining their plans for implementing the GIVS strategies and for attaining the GIVS Goals at the midpoint in 2010 or earlier. These goals are to: (1) reach ≥90% and ≥80% vaccination coverage at national and district level, respectively; and (2) reduce measles-related mortality by 90% compared with the 2000 level. Fifty cMYPs were analysed along the four strategic areas of the GIVS: (1) protecting more people in a changing world; (2) introducing new vaccines and technologies; (3) integrating immunization, other health interventions and surveillance in the health system context; and (4) immunizing in the context of global interdependence. By 2010, all 50 countries planned to have introduced hepatitis B (HepB) vaccine, 48 the Haemophilus influenzae type B (Hib) vaccine and only a few countries had firm plans to introduce pneumococcal or rotavirus vaccines. Countries seem to be inadequately prepared in terms of cold-chain requirements to deal with the expected increases in storage that will be required for vaccines, and in making provisions to establish a corresponding surveillance system for planned new vaccine introductions. Immunization contacts are used to deliver other health interventions, especially in the countries in the World Health Organization (WHO) Africa Region. The cost for the planned immunization activities will double to U$27 per infant, of which U$5 per infant is the expected shortfall. Global Alliance for Vaccines and Immunization (GAVI) funding is becoming the largest contributor to immunization programmes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411879     DOI: 10.1093/heapol/czs020

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  9 in total

Review 1.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

2.  Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Authors:  Patrick Lydon; Gian Gandhi; Jos Vandelaer; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2014-02-07       Impact factor: 9.408

3.  Drivers of routine immunization coverage improvement in Africa: findings from district-level case studies.

Authors:  Anne LaFond; Natasha Kanagat; Robert Steinglass; Rebecca Fields; Jenny Sequeira; Sangeeta Mookherji
Journal:  Health Policy Plan       Date:  2014-03-10       Impact factor: 3.344

4.  Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.

Authors:  Gian Gandhi; Patrick Lydon
Journal:  BMC Public Health       Date:  2014-01-22       Impact factor: 3.295

5.  Ideal and reality: do countries adopt and follow recommended procedures in comprehensive multiyear planning guidelines for national immunization programmes?

Authors:  Peter Mala; Patrick Zuber; Claudio Politi; Fred Paccaud
Journal:  Implement Sci       Date:  2015-04-12       Impact factor: 7.327

6.  Localization of health systems in low- and middle-income countries in response to long-term increases in energy prices.

Authors:  Sarah L Dalglish; Melissa N Poulsen; Peter J Winch
Journal:  Global Health       Date:  2013-11-07       Impact factor: 4.185

7.  Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.

Authors:  Debra D Kristensen; Tina Lorenson; Kate Bartholomew; Shirley Villadiego
Journal:  Vaccine       Date:  2016-01-08       Impact factor: 3.641

8.  Factors contributing to routine immunization performance in Ethiopia, 2014.

Authors:  Aschalew Teka Bekele; Braka Fiona; Karengera Thomas; Aron Kassahun; Gallagher Kathleen; Peter Nsubuga; Yohannes Ababu; Assefu Lemlem
Journal:  Pan Afr Med J       Date:  2017-06-09

9.  Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda.

Authors:  Ezekiel Mupere; Harriet M Babikako; Violet Okaba-Kayom; Robert B Mutyaba; Milton Nasiero Mwisaka; Emmanuel Tenywa; Albert Lule; Jane Ruth Aceng; Flavia Mpanga-Kaggwa; David Matseketse; Eresso Aga
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.